The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nebilet Plus 5 mg/25 mg film-coated tablets

Menarini International Operations Luxembourg S.A.PA0865/015/002

Main Information

Trade NameNebilet Plus 5 mg/25 mg film-coated tablets
Active SubstancesNebivolol
Dosage FormFilm-coated tablet
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/015/002

Group Information

ATC CodeC07BB Beta blocking agents, selective, and thiazides
C07BB12 nebivolol and thiazides


License statusAuthorised
Licence Issued13/03/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back